Imbiologics Corp.
π°π·South Korea
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)Study of NAV-240 in Healthy Volunteers
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2025-06-17
- Lead Sponsor
- Navigator Medicines, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06181786
- Locations
- πΊπΈ
Syneos Health, Miami, Florida, United States
News
No news found